From: Long-term effectiveness and safety of self-management of oral anticoagulants in real-world settings
Median time in therapeutic range (%) | P | |
---|---|---|
Overall (n = 476) a | 71.5 | |
Gender | < 0.026 | |
Male | 70.6 | |
Female | 72.6 | |
Target INR | < 0.001 | |
2.0–3.0 | 73.9 | |
2.5–3.5 | 65.6 | |
Other | 67.6 | |
Indication for anticoagulation | < 0.001 | |
Mechanical heart valve (n = 125) | 67.2 | |
Atrial fibrillation/ Atrial flutter (n = 178) | 73.5 | |
Venous and arterial thrombosis (n = 57) | 73.1 | |
Others (n = 93) | 71.7 |